Project Grant HT94252510975
Award Date 11/1/25
Completion Date 10/31/27
Dollars Obligated $400K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
- The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
- The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
- The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
- The University of Iowa will receive $772,480 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to delineate novel molecular pathways critical for the growth of GNAQ/11-mutant uveal melanoma cells. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative...
- The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The University of Iowa was awarded a $311,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying the temporal and spatial origins and reversibility of neurodevelopmental disorders with autism in mouse models. The grant, awarded on June 1, 2024, will fund this research project through May 31, 2026. The Military Medical Research and Development program supports biomedical...
- This $399,496 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The University of Iowa to study the effects of heel clearance on foot loading with carbon fiber custom dynamic orthoses. The grant period runs from July 1, 2024 to June 30, 2026. The University of Iowa, a major public research university, will leverage its expertise in medicine, engineering, and specialized laboratory services...
- The University of Iowa was awarded an $810,971 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The award will fund research from April 2021 through April 2024 to target a protumorigenic immunosuppressive loop in malignant peripheral nerve sheath tumors (MPNST). The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions for...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $233,250.00 to support research at the University of Iowa targeting Delta-like ligand 3 with gamma delta T cell engagers to treat neuroendocrine prostate cancer. The project aims to develop innovative medical solutions to address critical health challenges relevant to military personnel and the broader public. The award period runs from November 1, 2025 to...
- This $1,399,501 federal Project Grant awarded by the Defense Health Agency on September 1, 2023 will fund the development of a novel DNA aptamer-based IFN-γ targeted therapy for chronic cystitis pain at the University of Iowa. The project, which is scheduled for completion by August 31, 2027, aligns with the objectives of the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to transform healthcare for Service Members and the American public through...